It launched a combination drug Vildanat M (Vildagliptin and Metformin) for diabetes, to achieve better blood glucose control and improve therapy compliance.During the period 2019-20, NATCO Life ...
Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes.
When Is the Best Time to Take Metformin? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Timing is everything for many things in life — including when to take medication like ...
Also in combination with metformin and thiazolidinediones, sitagliptin and vildagliptin improve glycemic control with reduction of A1C of ~1%. Both sitagliptin and vildagliptin are safe and ...
Metformin hydrochloride (MTF) has pharmacological properties for managing inflammatory skin conditions. MTF is a hydrophilic medication. Accordingly, embedding MTF into lipid carriers for enhancing ...
Metformin is the most commonly prescribed drug used for the treatment of type 2 diabetes. Even so, not everyone responds to metformin in the same way, and, over time, the drug can start to lose its ...
Domestic brokerage firm Axis Securities has chalked out as many as 16 stocks including Trent, SBI, HDFC Bank, HCL Tech, Lupin and more for the month of February 2025. Sensex rose 5 pts to 77,506 ...
Along with lifestyle changes, metformin can help you get your blood sugar, also called blood glucose, under control. If your blood sugar is not controlled, metformin may not be working for you, and ...
The HCL journey has been relentless, gratifying and marked with a series of achievements. Our unified efforts have catapulted the company from a garage start-up to a conglomerate whose businesses span ...
Bonus May 05, 1995 Jun 01, 1995 Feb 16, 1995 Bonus Ratio: 1 share(s) for every 2 shares held Rights Aug 07, 1992 Sep 01, 1992 Sep 30, 1992 Rights ratio: 1 share for every 1 held at a price of Rs 60.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results